Lina Thors

513 total citations
24 papers, 419 citations indexed

About

Lina Thors is a scholar working on Plant Science, Pharmacology and Insect Science. According to data from OpenAlex, Lina Thors has authored 24 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Plant Science, 8 papers in Pharmacology and 5 papers in Insect Science. Recurrent topics in Lina Thors's work include Pesticide Exposure and Toxicity (11 papers), Cannabis and Cannabinoid Research (6 papers) and Advancements in Transdermal Drug Delivery (4 papers). Lina Thors is often cited by papers focused on Pesticide Exposure and Toxicity (11 papers), Cannabis and Cannabinoid Research (6 papers) and Advancements in Transdermal Drug Delivery (4 papers). Lina Thors collaborates with scholars based in Sweden, Czechia and United Kingdom. Lina Thors's co-authors include Anders Bucht, Christopher J. Fowler, C.J. Fowler, Elisabeth Wigenstam, Lars Hägglund, Bo Koch, Jan W. Eriksson, Anders Bergh, Pär Stattin and Peter Hammarsten and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Lina Thors

24 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lina Thors Sweden 13 190 172 63 46 43 24 419
Premrutai Thitilertdecha Thailand 11 57 0.3× 51 0.3× 25 0.4× 27 0.6× 122 2.8× 23 377
Davoud Ahmadimoghaddam Iran 12 40 0.2× 53 0.3× 26 0.4× 30 0.7× 83 1.9× 25 415
Harun Ün Türkiye 13 49 0.3× 25 0.1× 36 0.6× 72 1.6× 103 2.4× 30 465
Razif Abas Malaysia 9 45 0.2× 43 0.3× 58 0.9× 30 0.7× 95 2.2× 38 349
Sung‐Ki Jung South Korea 12 83 0.4× 82 0.5× 14 0.2× 14 0.3× 155 3.6× 56 500
Naceur A. Boughattas Tunisia 13 84 0.4× 50 0.3× 31 0.5× 41 0.9× 68 1.6× 33 413
Seyed Rafie Arefhosseini Iran 12 40 0.2× 126 0.7× 34 0.5× 16 0.3× 64 1.5× 26 460
M Ohara Japan 5 45 0.2× 118 0.7× 27 0.4× 27 0.6× 94 2.2× 12 411
Osama A. Alkhamees Saudi Arabia 10 35 0.2× 51 0.3× 58 0.9× 20 0.4× 71 1.7× 34 341
Şaziye Sezin Palabıyık Türkiye 12 34 0.2× 86 0.5× 13 0.2× 27 0.6× 57 1.3× 34 372

Countries citing papers authored by Lina Thors

Since Specialization
Citations

This map shows the geographic impact of Lina Thors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Thors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Thors more than expected).

Fields of papers citing papers by Lina Thors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Thors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Thors. The network helps show where Lina Thors may publish in the future.

Co-authorship network of co-authors of Lina Thors

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Thors. A scholar is included among the top collaborators of Lina Thors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Thors. Lina Thors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindén, Pernilla, Lina Mörén, Johanna Qvarnström, et al.. (2024). Field and laboratory perspectives on fentanyl and carfentanil decontamination. Scientific Reports. 14(1). 25381–25381. 1 indexed citations
2.
Wigenstam, Elisabeth, Elisabet Artursson, Anders Bucht, & Lina Thors. (2022). Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction. Chemico-Biological Interactions. 364. 110061–110061. 12 indexed citations
3.
Thors, Lina, et al.. (2022). Comparison of skin decontamination strategies in the initial operational response following chemical exposures. Toxicology in Vitro. 87. 105539–105539. 4 indexed citations
4.
Wigenstam, Elisabeth, et al.. (2021). Efficacy of atropine and scopolamine on airway contractions following exposure to the nerve agent VX. Toxicology and Applied Pharmacology. 419. 115512–115512. 8 indexed citations
5.
Larsson, Andreas, Johanna Qvarnström, Elisabeth Wigenstam, et al.. (2020). In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX. Toxicology Letters. 339. 32–38. 11 indexed citations
6.
Thors, Lina, et al.. (2020). Skin penetration and decontamination efficacy following human skin exposure to fentanyl. Toxicology in Vitro. 67. 104914–104914. 12 indexed citations
7.
Thors, Lina, Elisabeth Wigenstam, Johanna Qvarnström, Lars Hägglund, & Anders Bucht. (2020). Improved skin decontamination efficacy for the nerve agent VX. Chemico-Biological Interactions. 325. 109135–109135. 18 indexed citations
8.
Artursson, Elisabet, et al.. (2020). Decontamination efficacy of soapy water and water washing following exposure of toxic chemicals on human skin. Cutaneous and Ocular Toxicology. 39(2). 134–142. 16 indexed citations
9.
Thors, Lina, et al.. (2017). Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin. Chemico-Biological Interactions. 273. 82–89. 33 indexed citations
10.
Thors, Lina, et al.. (2017). RSDL decontamination of human skin contaminated with the nerve agent VX. Toxicology Letters. 269. 47–54. 26 indexed citations
11.
Nygren, U., et al.. (2017). Rapid breakthrough of 131I in an in vitro human epidermis model. Toxicology in Vitro. 42. 287–291. 3 indexed citations
12.
Thors, Lina, et al.. (2016). In vitro human skin penetration model for organophosphorus compounds with different physicochemical properties. Toxicology in Vitro. 32. 198–204. 22 indexed citations
13.
Fowler, Christopher J., Andreas Josefsson, Lina Thors, et al.. (2012). Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(10). 1579–1587. 4 indexed citations
14.
Thors, Lina, Anders Bergh, Emma Persson, et al.. (2010). Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4. PLoS ONE. 5(8). e12275–e12275. 62 indexed citations
15.
Thors, Lina, James J. Burston, Benedict J. Alter, et al.. (2010). Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. British Journal of Pharmacology. 160(3). 549–560. 39 indexed citations
16.
Thors, Lina & Christopher J. Fowler. (2009). Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids. European Journal of Pharmacology. 621(1-3). 10–18. 3 indexed citations
17.
Thors, Lina, et al.. (2008). Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. British Journal of Pharmacology. 155(2). 244–252. 41 indexed citations
18.
Thors, Lina, et al.. (2007). The ‘specific’ tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. British Journal of Pharmacology. 150(7). 951–960. 26 indexed citations
19.
Thors, Lina, Jan W. Eriksson, & C.J. Fowler. (2007). Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase‐driven uptake. British Journal of Pharmacology. 152(5). 744–750. 41 indexed citations
20.
Thors, Lina & C.J. Fowler. (2006). Is there a temperature‐dependent uptake of anandamide into cells?. British Journal of Pharmacology. 149(1). 73–81. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026